Artificial intelligence helps breast cancer patients avoid unnecessary chemotherapy

https://www.news-medical.net/news/20260623/Artificial-intelligence-helps-breast-cancer-patients-avoid-unnecessary-chemotherapy.aspx Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune markers that could help doctors more accurately determine which breast cancer patients are unlikely to benefit from chemotherapy, potentially sparing some patients from unnecessary treatment. Chemotherapy is regularly used in the treatment of early-stage, ER+HER2- breast cancer, which accounts for around 70% of all breast cancer diagnoses annually.